Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human CPD Antibodies:
anti-Mouse (Murine) CPD Antibodies:
anti-Rat (Rattus) CPD Antibodies:
Go to our pre-filtered search.
prolactin induction of VEGF-C and Runx2 was inhibited partly by Carboxypeptidase-D inhibitors, implicating nitric oxide , produced by PRL-regulated Carboxypeptidase-D, in breast cancer progression
Carboxypeptidase-D (CPD) overexpression coincides with high-grade lung cancer and the CPD overexpression could reverse the inhibitory effects of miR (show MLXIP Antibodies)-214
The human carboxypeptidase D transthyretin (show TTR Antibodies)-like domain forms amyloid under physiological conditions.
Prolactin (show PRL Antibodies) and R1881, acting through Stat5 (show STAT5A Antibodies) and androgen receptor (show AR Antibodies), act cooperatively to stimulate CPD gene transcription in breast cancer cells.
CPD immunostaining and testosterone/prolactin (show PRL Antibodies)-stimulated CPD expression were higher in prostate cancer than benign tissues/cells. Elevated CPD increased NO production, which was abolished when both androgen and prolactin (show PRL Antibodies) receptors were inhibited.
Carboxypeptidase D (CPD) is frequently upregulated in hepatocellular carcinoma; targeting CPD inhibits hepatocellular carcinoma cell proliferation through induction of G1 cell-cycle arrest and apoptosis.
Either high glucose or insulin (show INS Antibodies) (with low glucose) up-regulates beta-cell CPD (but not CPE (show CPE Antibodies)).
Palmitoylation of carboxypeptidase D has a role in intracellular trafficking
The isolation and characterization of CPD from several haematopoietic tumour cells are reported.
First report to demonstrate carboxypeptidase D as part of the transforming growth factor (TGF)-beta (show TGFB1 Antibodies) pathway as a TGF-beta (show TGFB1 Antibodies) target gene implicated in the pathogenesis of lupus erythematosus.
CPD localization to the TGN (show TG Antibodies) requires both static retention involving the C-terminal domain and phosphorylation at a CK2 (show CSNK2A1 Antibodies) site, which regulates the binding of adaptor proteins.
The carboxypeptidase D homolog silver regulates memory formation via insulin (show INS Antibodies) pathway in Drosophila.(
Individual carboxypeptidase D domains have both redundant and unique functions in Drosophila development and behavior.
the Drosophila silver gene corresponds to a Carboxypeptidase D-like protein with three carboxypeptidase-like domains, a transmembrane domain, and a cytosolic tail
The molecular basis for the phenotype of 3 carboxypeptidase D mutations are presented.
Data show that Drosophila S2 cells produce multiple forms of carboxypeptidase D with different intracellular distributions.
The metallocarboxypeptidase family of enzymes is divided into 2 subfamilies based on sequence similarities. The pancreatic carboxypeptidase-like and the regulatory B-type carboxypeptidase subfamilies. Carboxypeptidase D has been identified as a regulatory B-type carboxypeptidase. CPD is a homolog of duck gp180, a hepatitis B virus-binding protein. Transcript variants utilizing alternative polyadenylation signals exist for this gene.
, carboxypeptidase D
, carboxypeptidase E